Loading viewer...
investor_presentation
Format: PDF investor_presentation
Rieter Group's 2022 financial results presentation reporting CHF 1,510.9 million in sales and an EBIT margin of approximately 2%. The presentation outlines order intake of CHF 1,157.3 million, preparation for ITMA 2023, and ongoing implementation of the company's action plan to increase sales and profitability.
earnings
15 Pages
investor_presentation
36 Pages
Butterfly Network
Regeneron Pharmaceuticals Investor Presentation — September 2021
investor_presentationinvestor_presentation
31 Pages
Regeneron Pharmaceuticals, Inc.
Honeywell International Investor Presentation — April 2024
investor_presentationinvestor_presentation
28 Pages
Honeywell International Inc.